Why is Guj. Themis Bio. falling/rising?

As of 01-Aug, Gujarat Themis Biosyn Ltd's stock price is currently at Rs. 371.85, reflecting a decrease of Rs. 19.35 or 4.95%. Today, the stock reached a new 52-week high of Rs. 404.9 but has also experienced significant volatility, trading in a wide range of Rs. 40.35, with an intraday low of Rs. 364.55. Despite a positive performance over the past month (+6.56%) and year-to-date (+21.74%), the stock has underperformed its sector by 1.79% today. The company benefits from high management efficiency, a low debt-to-equity ratio, and increasing participation from institutional investors, which collectively hold 3.69% of the company, indicating a strong fundamental outlook despite the current price decline.
Broader market context shows that while Gujarat Themis Biosyn Ltd has performed well over the past year (+14.62%) and significantly over three years (+437.50%), the broader pharmaceutical sector has declined by 3.27%. Additionally, the stock's recent drop may be influenced by falling investor participation, with delivery volume decreasing by 60.31% against the five-day average. In the short term, the stock has outperformed the Sensex over the past week (+2.44% vs. -1.06%) and month (+6.56% vs. -3.70%), suggesting that while the stock is currently facing downward pressure, its longer-term performance remains strong relative to the broader market.